HCPLive

The Flu Vaccine is Safe in Children with Severe Egg Allergy

 
WEDNESDAY, Jan. 30 (HealthDay News) -- Children with a history of severe egg allergy, even anaphylaxis, can safely receive a single dose of trivalent seasonal influenza vaccine (TIV), according to a study published in the December issue of the Annals of Allergy, Asthma & Immunology.

Matthew J. Greenhawt, M.D., M.B.A., from the University of Michigan Health System in Ann Arbor, and colleagues randomly assigned 31 children with a history of a severe reaction after eating eggs (45.1 percent with a history of anaphylaxis) and an antibody response to egg to receive either 0.1 mL of influenza vaccine or saline followed by the remainder of the age-appropriate dose or the full dose after 30 minutes if there was no reaction. An additional retrospective study was conducted of 112 children (77.6 percent with a history of anaphylaxis) who had declined to participate in the trial and who had received either a split dose or a single dose of TIV.

The researchers found that none of the children in the randomized or retrospective studies developed an allergic reaction after receiving TIV. The use of split dosing was found to be unnecessary.

"TIV administration is safe even in children with histories of severe egg allergy," Greenhawt and colleagues conclude. "We believe these findings support further revision of the Advisory Committee on Immunization Practices guidelines to recommend that children with egg allergy of any severity, including anaphylaxis, should receive TIV as a single injection with a 30-minute observation period and do not require referral to an allergist for influenza vaccination."
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 

Most Popular

Recommended Reading

Genetic mutations may increase risk of acute and chronic pancreatitis in patients who are also heavy smokers and drinkers.
Multicenter phase II study will also evaluate pharmacokinetics of omega-3 carboxylic acids and omega-3-acid ethyl esters administered to patients with varying degrees of EPI.
Study results show that treatment with atorvastatin lowers LDL-cholesterol levels and reduces the volume of noncalcified and high-risk plaques in HIV-infected patients with subclinical atherosclerosis.
Cultural barriers, poor treatment adherence, and other factors thwart efforts to provide effective anti-HIV acquisition measures for women in Africa.
$vAR$